Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
362,95 B | 2,49% | 4/6 | 25,40% | -30,10% | 21,83% | DOWN |
|
Amgen NasdaqGS:AMGN |
187,83 B | 7,37% | 3/6 | 2,72% | -7,35% | 0,45% | UP |
|
Gilead Sciences NasdaqGS:GILD |
171,43 B | 3,30% | 5/6 | 4,57% | -57,02% | 15,85% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
40,86 B | 46,06% | 4/6 | 49,94% | 6,67% | 46,08% | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Biogen NasdaqGS:BIIB |
27,00 B | -10,57% | 1/6 | -1,25% | 4,68% | 12,26% | UP |
|
Incyte NasdaqGS:INCY |
18,04 B | 41,79% | 5/6 | 9,11% | 30,93% | 18,08% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,40 B | 12,22% | 5/6 | 45,50% | 59,97% | 73,78% | DOWN |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
7,88 B | 48,13% | 5/6 | -45,97% | 27,13% | 42,17% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,53 B | 19,97% | 5/6 | 56,83% | -25,17% | 0,62% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,72 B | 0,00% | 0/4 | 0,00% | 0,00% | 209,29% | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,57 B | 29,02% | 5/6 | 16,99% | 32,85% | 55,06% | DOWN |
|
ADMA Biologics NasdaqGM:ADMA |
2,70 B | 45,53% | 5/6 | 33,35% | -38,22% | 164,78% | DOWN |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
2,82 B | 40,93% | 5/6 | 5,59% | 27,91% | 51,71% | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
2,47 B | 10,07% | 5/6 | 43,61% | -36,09% | 60,51% | UP |
